Targeted deletion of the Nf2 gene in the mouse liver (albumin-Cre driver specific for hepatocytes and biliary cells) led to increased Yap activation, increased cell proliferation, increased liver size and eventual hepatocellular carcinoma (HCC)[99],[100]. The gene discussed is NF2; the disease is hepatocellular carcinoma.